Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor?
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to
Technology
Ideas for Managing Clinical Trial Finances Post-Pandemic
While the pandemic’s long-lasting effects on clinical trials are not yet fully known, effective financial management is a critical component
How to Design Digital Materials for Participant Engagement
Informative and engaging participant materials are an important part of any clinical trial, especially during the recruitment process. Traditionally, many
Key CTMS Capabilities to Improve Financial Management
A well-utilized CTMS streamlines financial workflows, automates participant payments, tracks budgets, and centralizes data, helping clinical sites maximize ROI and efficiency.
Effective Clinical Trial Financial Management Post-Pandemic
Explore strategies for post-pandemic clinical trial financial management, from cost recovery to adapting to evolving participant expectations.
Beginner’s Guide to IND Safety Reporting Under 21 CFR 312(c)
Read about IND safety reporting required under FDA 21 CFR 312.32(c), challenges faced in adhering to the regulation, and strategies to ensure compliance.
Site-Driven Metrics: Operational Data To Improve Research
The true value of metrics is to measure operational performance in order to improve internal processes. In clinical research, this is highly beneficial when applied where the work is conducted: at the sites.
Site Technology Guide for Facilitating GCP in Decentralized Trials
Explore GCP considerations for decentralized trials and discover how secure site technology can streamline oversight and management.
Addressing Barriers to DEI in Clinical Research
Breaking down barriers to participation in clinical research has long been a challenge, affecting every aspect of the industry. As
Making the Most of Site Training: Lessons from the Pandemic
The shift to virtual site training reveals innovative ways to maintain engagement and consistency, enhancing site readiness in remote settings.
The Power Of Patient Advocacy In Drug Development
Recently, we discussed the importance of connecting with advocacy groups in order to create more trial diversity. As a result
Q&A from Remote Monitoring: Study Compliance In A Changing World
In a recent webinar, Advarra experts Emily Eldh and Ben Shankle provided insights and information in Remote Monitoring: Study Compliance